The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADVERUM BIOTECHNOLOGIES INC | Common | 00773U108 | 60,480 | 5,250,000 | SH | SOLE | 5,250,000 | 0 | 0 | ||
| ALIMERA SCIENCES INC | Common | 016259202 | 3,153 | 415,999 | SH | SOLE | 415,999 | 0 | 0 | ||
| ALLOGENE THERAPEUTICS INC | Common | 019770106 | 29,321 | 1,128,594 | SH | SOLE | 1,128,594 | 0 | 0 | ||
| AMARIN CORP PLC | Sponsored ADR | 023111206 | 40,736 | 1,900,000 | SH | SOLE | 1,900,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 109,088 | 11,200,000 | SH | SOLE | 11,200,000 | 0 | 0 | ||
| ARGENX SE | Sponsored ADR | 04016X101 | 150,327 | 936,500 | SH | SOLE | 936,500 | 0 | 0 | ||
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 259,459 | 1,865,000 | SH | SOLE | 1,865,000 | 0 | 0 | ||
| ATHENEX INC | Common | 04685N103 | 80,342 | 5,261,437 | SH | SOLE | 5,261,437 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | Common | 09060J106 | 18,960 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 169,100 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| CONSTELLATION PHARMACEUTICALS INC | Common | 210373106 | 171,952 | 3,650,000 | SH | SOLE | 3,650,000 | 0 | 0 | ||
| CUE BIOPHARMA INC | Common | 22978P106 | 29,686 | 1,870,000 | SH | SOLE | 1,870,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | Common | 23257D103 | 10,780 | 5,500,000 | SH | SOLE | 5,500,000 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS INC | Common | 24344T101 | 3,960 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
| DECIPHERA PHARMACEUTICALS INC | Common | 24344T101 | 1,050 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
| DECIPHERA PHARMACEUTICALS INC | Common | 24344T101 | 31,120 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | Common | 31447P100 | 7,167 | 1,105,999 | SH | SOLE | 1,105,999 | 0 | 0 | ||
| HORIZON THERAPEUTICS PLC | Common | G46188101 | 144,800 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 518,420 | 24,500,000 | SH | SOLE | 24,500,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 244,305 | 8,826,039 | SH | SOLE | 8,826,039 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | Common | 48576U106 | 113,103 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 31,797 | 349,000 | SH | SOLE | 349,000 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | Common | 56854Q101 | 13,392 | 6,200,000 | SH | SOLE | 6,200,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | 496,137 | 3,850,200 | SH | SOLE | 3,850,200 | 0 | 0 | ||
| MYOKARDIA INC | Common | 62857M105 | 112,243 | 1,540,000 | SH | SOLE | 1,540,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | Common | 803607100 | 227,110 | 1,760,000 | SH | SOLE | 1,760,000 | 0 | 0 | ||
| SEATTLE GENETICS INC | Common | 812578102 | 150 | 75,000 | SH | Call | SOLE | 75,000 | 0 | 0 | |
| TG THERAPEUTICS INC | Common | 88322Q108 | 11,100 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| TRICIDA INC | Common | 89610F101 | 58,874 | 1,560,000 | SH | SOLE | 1,560,000 | 0 | 0 | ||
| UNIQURE NV | Common | N90064101 | 121,822 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | Common | 98420N105 | 31,464 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
| ZOGENIX INC | Common | 98978L204 | 104,260 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||